Abstract: Initially, it is important to make distinction between liver function andliver enzyme which include, serum aminotransferases level and alkalinephosphatase level. Their elevations indicate hepatocyte and bile ductepithelial injury. However, albumin, bilirubin and prothrombin time are measures of hepatic function. But, these are affected by extrahepatic factors such as nutrition, hemolysis and antibiotic use.
Introduction
Standard laboratory tests for liver function are oftenrequested bydoctors in patients with non-specificsymptoms such as tiredness,abdominal pain, dyspepsia, and weight loss. Considerableuncertaintyexists asto the appropriate follow up of mildly abnormal resultsinpatients with no signs suggestive of liver disease. [1, 2] Aminotransferases are among the most wildly use test and notspecifically to the liver, althgh they are wildly use as liver enzymes.Aspartate transaminase (AST) is found in liver, muscle, heart,kidney, red cell and brain.Alanine aminotransferase (ALT) little more specific to the liver, and found in muscle and kidney. [1] [2] [3] ALT is thoughtto be more specific for hepatic injury becauseit is presentmainly in the cytosol of the liverand in low concentrations elsewhere. ASThas cytosolic and mitochondrial forms andis present in tissues of the liver, heart, skeletalmuscle, kidneys, brain, pancreas, andlungs, and in white and red blood cells. ASTis less commonly referred to as serum glutamicoxaloacetic transaminase and ALT asserum glutamic pyruvic transaminase. [1] [2] [3] Blood tests commonly obtained to evaluate the health of the liver include liver enzyme levels alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, gamma-glutamyl transferase), tests of hepatic synthetic function (albumin, prothrombin time/international normalized ratio (INR)), and the serum bilirubin level. [1] [2] [3] [4] [5] [6] The initial evaluation of a patient with abnormal liver biochemical and function tests (LFTs) includes obtaining a history to identify potential risk factors for liver disease and performing a physical examination to look for clues to the etiology and for signs of chronic liver disease. Subsequent testing is determined based on the information gathered from the history and physical examination as well as the pattern of LFT abnormalities. [1] [2] [3] [4] [5] [6] The child-Pugh score is perhaps the best indicator of liver function in patient with cirrhosis and MELD score measures more than liver function. [7] [8] [9] [10] The Child-Pugh score is still consideredthe cornerstone in the prognostic evaluation ofcirrhotic patients although it was formulated more than 30years ago. Nevertheless, it has some drawbacks such assubjectivity of clinical parameters and limited discriminateability. [7] [8] [9] [10] Child-Pugh class A patients usually show good mediumterm survival withoutorthotropic liver transplantation (OLT) unless other events (for example,hepatocellular carcinoma, uncontrolled bleeding due to portalhypertension, etc) occur, [10] while Child-Pugh class C patientsare considered the conventional candidates for the procedure.Child-Pugh class B patients can be considered a heterogeneousgroup as their clinical condition may remain stable formore than a year or rapidly deteriorate. [7.11] MELDscoring system is useful for predicting prognosis inpatients with liver cirrhosis and is correlated with residual liver function. It predictor of bothshort and medium term survival, and performs at least as well as the Child-Pugh score. An increase inMELD score is associated with a decrease in residual liver function. [12] The Model for EndStage Liver Disease (MELD) consists of serum bilirubin and creatinine levels, International Normalized Ratio (INR) for prothrombin time, and etiology of liverdisease. [12] Recently, the model for end stage liver disease (MELD) wasintroduced as a tool to predict mortality risk and to assessdisease severity in patients with liver cirrhosis so as todetermine organ allocation priorities. [12] Although previously formulated as a prognostic index for cirrhotic patientsundergoing transjugular intrahepatic portosystemic stentshunt (TIPSS), it was validated by the same authors on abroad series of patients with liver disease of various aetiologyand severity. [13, 14] Nevertheless, although the MELD score takesinto consideration objective parameters (serum creatinine,the international normalized ratio (INR), bilirubin levels)and is computed with statistically derived coefficients on acontinuous scale with no upper or lower limits, thus avoidingmany drawbacks of the Child-Pugh score, it has generatedsome criticism. [15, 16] 
Properties
Alanine aminotransferase (ALT) exclusively in cytoplasm whereas aspartate transaminase (AST), is both cytoplasm and mitochondrial. The half life of total AST is 17 +/-5 hours, whereas ALT is 47 +/-10 hour. AST/ALT ratio depend on gender, age and sex. [3, 17] The aminotransferases (formerly transaminases)are themost frequently utilized and specific indicators ofhepatocellular necrosis. These enzymes-aspartateaminotransferase(AST, formerly serum glutamateoxaloacetic transaminase-SGOT) and alanine aminotransferase( ALT, formerly serum glutamic pyruvatetransaminase-SGPT) catalyze the transfer of the á aminoacids of aspartate and alanine respectively to the á ketogroup of ketoglutaric acid. ALT is primarily localized tothe liver but the AST is present in a wide variety of tissueslike the heart, skeletal muscle, kidney, brain and liver. [18, 19] Etiology of aminotransferase of non hepatic causes are hemolysis, myocardial infarction, acute renal injury, infracted bowel, brain injury, and macroenzymes. [20] Alkaline phosphates are a family of zincmetaloenzymes, with a serine at the active center; theyrelease inorganic phosphate from various organicorthophosphates and are present in nearly all tissues. Inliver, alkaline phosphatase is found histochemically in themicrovilli of bile canaliculi and on the sinusoidal surfaceof hepatocytes. Alkaline phosphatase from the liver, boneand kidney are thought to be from the same gene but thatfrom intestine and placenta are derived from differentgenes. [20] G Glutamyl transpeptidase(GGT) or 5nucleotidase can help hepatic vs. nonhepatic source because of elevatedparallel to alkaline phosphatase. Alkaline phosphatase elevated physiologically in whom less than 18 years old, or pregnant woman. [21] ALP Largely originate from the liver, mainly cells lining biliary ducts or membranes adjoining the bile canaliculi, and bones Marked increase is typical of cholestasis (often with raised GGT) Variety of bone disorders (usually without raised GGT) Isoenzymes may be useful for distinguishing these sources. [21] [22] [23] [24] [25] [26] [27] [28] [29] Gamma GT Found in the hepatocytes and biliary epithelial cells. Sensitive in detecting hepatobiliary disease but limited by lack of specificity Best used to evaluate elevation of other enzymes High GGT with otherwise normal liver should not lead to exhaustive work up for liver disease Twofold elevation with AST:ALT ratio2:1suggest alcohol abuse. [1, 2, [30] [31] [32] [33] [34] [35] Albumin is synthesized in the liver Albumin has a plasma half-life of three weeks; therefore, serum albumin concentrations change slowly in response to alterations in synthesis. In practice, patients with low serum albumin concentrations and no other LFT abnormalities are likely to have a nonhepatic cause for low albumin, such as proteinuria or an acute or chronic inflammatory state. [1, 2, [30] [31] [32] [33] [34] [35] Albumin synthesis isaffected not only in liver disease but also by nutritionalstatus, hormonal balance and osmotic pressure. [20] The serum levels are typically depressed in patientswith cirrhosis and ascites. In patients with or withoutascites, the serum albumin level correlates with prognosis. [36] In addition the rate of albumin synthesis hasbeen shown to correlate with the Child-Turcotte orChild-Pugh score. [37] Corticosteroids and thyroid hormone stimulatealbumin synthesis by increasing the concentration ofalbumin mRNA and tRNA in hepatocytes. [38] The serum albumin levels tend to be normal indiseases like acute viral hepatitis, drug relatedhepatotoxicity and obstructive jaundice.Albumin levelsbelow 3g/dl in hepatitis should raise the suspicion ofchronic liver disease like cirrhosis which usually reflectsdecreased albumin synthesis. In ascites there may benormal synthesis but the levels may appear reducedbecause of increased volume of distribution. [39, 40] Hypoalbuminemia is not specific for liver disease andmay occur in protein malnutrition, nephrotic syndromeand chronic protein losing enteropathies. [41] Prothrombin time (PT) not usually included in the LFTs panel.Abnormal PT prolongation may be a sign of serious liver dysfunction. An elevated PT can result from a vitamin K deficiency ,a trial of vitamin K injections is the most practical way to exclude vitamin K deficiency in such patients. [1, 2, [30] [31] [32] [33] [34] [35] The liversynthesizes both albumin and many of the blood coagulationfactors that are required to be in adequate concentrationsin order for the prothrombin time to be normal.Thus, in the absence of other nonhepatic etiologies forabnormalities in the albumin orprothrombin time, theselaboratory tests can be useful in assaying hepatic syntheticfunction. The half-life of serum albumin normallyis [19] [20] [21] days, whereas the half-life of blood coagulationfactors may be less than a day, so these tests often can beused in tandem to assess both acute and chronic componentsof hepatic function or impairment. The prothrombintime may be a better indicator of coagulation in liverdiseases than the international normalization ratio. [42] [43] [44] Bilirubin is derived from the breakdown of haem in the red blood cells within the reticuloendothelial system.The unconjugated bilirubin then binds albumin and is taken up by the liver.In the liver, it is conjugated which then makes it water-soluble and thus allows it to be excreted into the urine.Normally total serum bilirubin is measured; however, the unconjugated and conjugated portions can be determined by measures of the fractions of indirect bilirubin and direct bilirubin respectively. [45] The classificationof bilirubin into direct and indirect bilirubin are based onthe original van der Bergh method of measuringbilirubin. Bilirubin is altered by exposure to light so serum and plasmasamples must be kept in dark before measurements are made. [19] Unlike serum liver chemistry tests like the serum ALT,AST, and alkaline phosphatase (which are not true indicatorsof hepatic function), serum albumin levels andprothrombin time, along with physical examinationfindings such as encephalopathy, are important clinicalparameters of hepatic function that are essential in thecontext of interpreting abnormal serum liver chemistrytests, especially in clinical scenarios of impendinghepaticfailure. [46, 47] 
Patterns of Liver Disease
The abnormal liver enzymes are charactrized by either acute or chronic of cutt off six month which is either hepatocllular or cholestatic or mixed. Injury to the liver, whether acute or chronic, eventually results in an increase in serum concentrations of aminotransferases. [1, 48] Based on the pattern of the serum liver chemistryabnormalities, serum liver chemistry tests can be classifiedto provide a practical approach for the evaluation anddiagnosis of hepatobiliary diseases. For the purpose ofthis document, we have classified the analysis of liverchemistry abnormalities to the interpretation of serumALT and aspartate aminotransferase (AST) abnormalities(hepatocellular injury) and serum alkaline phosphataseand bilirubin abnormalities (cholestatic pattern). Althoughit is important to emphasize that liver chemistrytest abnormalities frequently occur in overlapping patterns,presenting an obvious limitation to this type ofcategorized analysis, the division of liverchemistry testabnormalities into "hepatocellular injury" and"cholestatic"patterns allows a commonly used, simplified approachfor the interpretation of serum liver chemistries.In addition, elevations of the hepatic alkaline phosphatasewith minimal or no elevations of the serum ALT,AST, or bilirubin also may be indicative of "infiltrative"diseases of the hepatic parenchyma. Blood tests such asserum albumin and prothrombin time are also importantdeterminants of hepatic synthetic function, but are notspecific for hepatic disease. Nonetheless, these tests havean essential role in the evaluation of the hepatic functionof patients with acute or chronic liver diseases. [49] [50] [51] Although levels of ALT and AST can beextremely elevated (exceeding 2,000 U per Lin cases of hepatocyte injury and necrosisrelated to drugs, toxins, ischemia, -related, herpes simplex virus, acetamiophenon, andhepatitis. Howevere, fatty liver, hemochromatosis and alfa one antitrypsin deficiency are the etiology of chronic liver.The both acute and chronic hepatitis etilology include autoimmune, Wilson's Disease, hepatitis B, Bud-chiari syndrome, alcoholic liver disease andmedication.The cause of extracholestatic liver diseaseare stone, cancer, sphinector dysfunction and choledochal cyst or trauma.The cause ofintracholestatic liver disease are primary biliary cirrhosis cholangitis, sepsis, drugs, granulomas, total parenteral nutrition, and metastases.While both intra and extracholestasis liver disease are primary sclerosing cholangitis, cholangiocarcinoma and radiation. [49] [50] [51] [52] [53] 
Clinical Value of Different Patterns & Level
In almost all liver disease, ALT is higher than AST except in alchoholic liver disease and advanced liver fibrosis. In alchoholic hepatitis, ASTis greater than ALT. Alchol increases mitochondrial AST and decrease cytoplasmic ALT. ALT is also low due to pyridoxine deficiency. [54] AST and ALT are significantly lower inpatients with renal failure. [55] Normal ALT in patients with hepatitis C virus (HCV) may still be associated with abnormal hepatic histology. [56] Level less than 300U/L in chronic HCV/HBV, NAFLD and hemochromatosis. [57] ALT more than 150 or AST more than 300U/L is uncommon in alcholic liver disease. [54] Aminotransferase can be elevated in the contex of other abnormalities with raise bilirubin such as hemolysis, Gilbert's, and obstruction. In Wilson's will found very high level of aminotransferases and hemolysis. However, very high level of aminotransferases with new onset ascites found in cardiac or Budd-Chiari. Very high level of aminotransferases and LDH found in ischemic hepatitis, with high CPK in rhabdomyolysis. [58] The ratio of AST to ALT has some clinicalutility, but has important limitations. In manyforms of acute and chronic liver injury or steatosis(fatty infiltration of the liver), the ratiois less than or equal to 1. This is particularlytrue in patients with hepatitis C. However, anAST/ALT ratio greater than 2 characteristicallyis present in alcoholic hepatitis. A recent studyof 140 patients with nonalcoholic steatohepatitis(NASH; confirmed by liver biopsy) oralcoholic liver disease found a meanAST/ALTratio of 0.9 in patients with NASH and 2.6 inpatients with alcoholic liver disease. [58] Withinthe population studied, 87 percent ofpatientswith an AST/ALT ratio of 1.3 or less had NASH(87 percent sensitivity, 84 percent specificity).The severity of NASH as measured bythe degree of fibrosis increased, as did theAST/ALT ratio. A mean ratio of 1.4 was foundin patients with cirrhosis related to NASH. [58] Wilson's disease, a rare problem, can cause theAST/ALT ratio to exceed 4.5 While these ratiosare suggestive of certain conditions, there istoo much overlap between groups to rely onthem exclusively when making a diagnosis. [58] The AST and ALT levels are increased to some extent in almost all liver diseases. The highest elevations occur in severe viral hepatitis, drug or toxin induced hepatic necrosis and circulatory shock. Although enzyme levels may reflect the extent of hepatocellular necrosis they do not correlate with eventual outcome. In fact declining AST and ALT may indicate either recovery of poor prognosis in fulminant hepatic failure. [19, 20] The AST and ALT aremoderately elevated in acute hepatitis, neonatal hepatitis,chronic hepatitis, autoimmune hepatitis, drug inducedhepatitis, alcoholic hepatitis and acute biliary tractobstructions.
The ALT is usually more frequentlyincreased as compared to AST except in chronic liverdisease. In uncomplicated acute viral hepatitis, the very high initial levels approach normal levels within 5 weeksof onset of illness and normal levels are obtained in 8weeks in 75% of cases.For reasons, which are not, understood AST levelsappear disproportionately low in patients with Wilsondisease. [19, 20] The ratio of AST to ALT is of use in Wilson disease,chronic liverdisease(CLD)and alcoholic liver disease and a ratio of more than 2 isusually observed. The lack of ALT rise is probably due topyridoxine deficiency. In NASH the ratio is less than onein the absence of fibrosis on liver biopsy. [19] In viral hepatitis the ratio is usually less than one. Theratio invariably rises to more than one as cirrhosisdevelops possibly because of reduced plasma clearance ofAST secondary to impaired function of sinusoidal cells.
[59] ALT exceeds AST in toxic hepatitis, viral hepatitis,chronic active hepatitis and cholestatic hepatitis. [20] 
Conclusion

